Could new cancer drugs come from potatoes and tomatoes?
Credit: CC0 Public Domain

Everyone knows someone who has had cancer. In 2020, around 19 million new cases—and around 10 million deaths—were registered worldwide. Treatments are improving all the time, but can damage healthy cells or have severe side effects that are hard on patients. In the search for new, more targeted cancer drugs, traditional medicine offers many possible candidates.

A team of Polish scientists led by Magdalena Winkiel at Adam Mickiewicz University, publishing today in Frontiers in Pharmacology, has reviewed the bioactive compounds called glycoalkaloids, found in vegetables like potatoes and tomatoes, to demonstrate their potential to treat cancer.

“Scientists around the world are still searching for the drugs which will be lethal to cancer cells but at the same time safe for healthy cells,” said Winkiel.

“It is not easy despite the advances in medicine and powerful development of modern treatment techniques. That is why it might be worth going back to medicinal plants that were used years ago with success in the treatment of various ailments. I believe that it is worth reexamining their properties and perhaps rediscovering their potential.”

Making medicine from poison

Winkiel and her colleagues focused on five glycoalkaloids—solanine, chaconine, solasonine, solamargine and tomatine—that are found in crude extracts of the Solanaceae family of plants, also known as nightshades. This family contains many popular food plants, and many that are toxic, frequently because of the alkaloids they produce as a defense against animals that eat plants. But the correct dose can turn a poison into a medicine: Once scientists have found a safe therapeutic dose for alkaloids, they can be powerful clinical tools.

Glycoalkaloids in particular inhibit cancer cell growth and may promote cancer cell death. These are key target areas for controlling cancer and improving patient prognoses, so have huge potential for future treatments. In silico studies—an important first step—suggest that the glycoalkaloids aren’t toxic and don’t risk damaging DNA or causing future tumors, although there may be some effects on the reproductive system.

“Even if we cannot replace anti-cancer drugs that are used nowadays, maybe combined therapy will increase the effectiveness of this treatment,” Winkiel suggested. “There are many questions, but without detailed knowledge of the properties of glycoalkaloids, we will not be able to find out.”

From tomatoes to treatments

One necessary step forward is using in vitro and model animal studies to determine which glycoalkaloids are safe and promising enough to test in humans. Winkiel and her colleagues highlight glycoalkaloids derived from potatoes, like solanine and chaconine—although the levels of these present in potatoes depend on the cultivar of potato and the light and temperature conditions to which the potatoes are exposed.

Solanine stops some potentially carcinogenic chemicals from transforming into carcinogens in the body and inhibits metastasis. Studies on a particular type of leukemia cells also showed that at therapeutic doses, solanine kills them. Chaconine has anti-inflammatory properties, with the potential to treat sepsis.

Meanwhile, solamargine—which is mostly found in eggplant—stops liver cancer cells from reproducing. Solamargine is one of several glycoalkaloids that could be crucial as a complementary treatment, because it targets cancer stem cells which are thought to play a significant role in cancer drug resistance.

Solasonine, which is found in several plants from the nightshade family, is also thought to attack cancer stem cells by targeting the same pathway. Even tomatoes offer potential for future medicine, with tomatine supporting the body’s regulation of the cell cycle so that it can kill cancer cells.

Further research will be needed to determine how this in vitro potential can best be turned into practical medicine, Winkiel and her team noted. There is some reason to believe that high-temperature processing improves glycoalkaloid properties, and nanoparticles have recently been found to improve transmission of glycoalkaloids to cancer cells, boosting drug delivery.

However, the glycoalkaloids’ mechanisms of action must be better understood, and all potential safety concerns must be scrutinized, before patients can benefit from cancer drugs straight out of the vegetable patch.

More information: Anticancer activity of glycoalkaloids from Solanum plants: a review, Frontiers in Pharmacology (2022). DOI: 10.3389/fphar.2022.979451

Journal information: Frontiers in Pharmacology

Provided by Frontiers

Citation: Could new cancer drugs come from potatoes and tomatoes? (2022, December 7) retrieved 7 December 2022 from https://phys.org/news/2022-12-cancer-drugs-potatoes-tomatoes.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

NEWS RELATED

TikTok’s chief executive to testify before Congress in March

The chief executive of TikTok, Chew Shou Zi, has agreed to testify to Congress in March on the video app’s relationship with the Chinese Communist Party, it was announced Monday. Representative Cathy McMorris Rodgers, Republican of Washington, who chairs the House Energy and Commerce Committee said that Chew would ...

View more: TikTok’s chief executive to testify before Congress in March

Honda retains lead in motorcycle market

Thai Honda Co, a manufacturer and distributor of Honda motorcycles, has maintained its top rank in Thailand's motorcycle market for the 34th consecutive year, with sales standing at 1.38 million units in 2022. Honda motorcycles were ranked number one in all segments, covering the family, automatic (AT) and sports ...

View more: Honda retains lead in motorcycle market

Head of Australian Antarctic Division to step down

The head of the Australian Antarctic Division has announced his resignation ahead of the finalisation of a review into workplace culture. Kim Ellis, who took up the role in 2019, has announced his retirement, the division said on Tuesday. It is reported Mr Ellis will step down in coming ...

View more: Head of Australian Antarctic Division to step down

STYLE Edit: Meet Lilou Wadoux, Ferrari’s first female Competizioni GT driver with Richard Mille Racing Team, who will ride the Ferrari 488 GTE with the AF Corse team in March

Richard Mille Racing Team protégé Lilou Wadoux is set to become the first female Ferrari Competizioni GT driver at Le Mans. The 21-year-old French woman from Amiens will join the starting grid at the wheel of the Ferrari 488 GTE with the AF Corse team, hoping to make a ...

View more: STYLE Edit: Meet Lilou Wadoux, Ferrari’s first female Competizioni GT driver with Richard Mille Racing Team, who will ride the Ferrari 488 GTE with the AF Corse team in March

ChatGPT-connected companies like BuzzFeed see stock volume surges in enthusiasm over OpenAI

Companies tied to artificial intelligence services recorded some of their highest trading volumes on record this month, amid a frenzy of interest in the ChatGPT tool, which generates conversation-style interactions. BuzzFeed Inc, C3.ai Inc, SoundHound AI Inc, and BigBear.ai Holdings Inc are among the stocks that have all seen ...

View more: ChatGPT-connected companies like BuzzFeed see stock volume surges in enthusiasm over OpenAI

Can you teach a computer common sense?

Dr. Yejin Choi University of Washington Professor and MacArthur Fellow, works to improve AI’s understanding of common sense. John D. and Catherine T. MacArthur Foundation hide caption toggle caption John D. and Catherine T. MacArthur Foundation The first time Short Wave co-host Emily Kwong ever “spoke” to a computer ...

View more: Can you teach a computer common sense?

New cancer treatment found ‘promising’ for terminally ill dogs

A new therapy to treat late-stage cancer in dogs can not only extend the lives of canines but also preserve “good quality of life”, according to a new study that may also lead to improved treatments for some cancers that affect humans. The research, published recently in the journal ...

View more: New cancer treatment found ‘promising’ for terminally ill dogs

Cryptocurrency entrepreneur and Huobi adviser Justin Sun plans move to Hong Kong while talking up China market

Chinese cryptocurrency personality Justin Sun said he is planning to move to Hong Kong, where the government recently announced new policies to attract virtual asset businesses, and talked up the potential of China’s crypto industry, while the global industry remains in a slump after the collapse of FTX. “China’s ...

View more: Cryptocurrency entrepreneur and Huobi adviser Justin Sun plans move to Hong Kong while talking up China market

Obesity can trigger Alzheimer’s symptoms, new study suggests

Watch distant worlds dance around their sun: Stunning timelapse shows exoplanets orbiting their star 133 light-years away from Earth

A mysterious flying spiral above Hawaiian night sky likely caused by SpaceX launch

Bring back the dodo bird? Ambitious plan draws investors, critics

Glowing material may cut out internal stitches

Xiaomi looks to improve decision-making with new governance bodies in wake of management reshuffles, slumping sales

Mars shines bright in night sky as it vanishes behind moon

Dolphins and humans can team up to go fishing. Scientists now understand why.

EPA blocks mine project that threatened crucial Alaskan salmon runs

China’s Henan province, home to the world’s largest iPhone factory, pushes US$7 billion digital infrastructure expansion programme

Giant sea scorpion species discovered in New Mexico

Five healthy digital habits It's not too late to make resolutions that will make your digital life safer and more convenient, say Kaspersky experts

OTHER NEWS